Skip to main content
You are reading the English-mode interface. Some article body content is currently Chinese-only; full translation is in progress. Switch to Chinese
Ophthalmology Patient-Education Notes

From the clinic to your everyday eyes.

A resident ophthalmologist's field notes — patient questions, new evidence, and the everyday basics of eye care: dry eye, childhood myopia control, cataract, glaucoma, and retinal detachment.

Quick find by topic
Latest Articles

What clinic doesn't have time to explain.

Latest Research Pediatric myopia Axial length

Childhood High Myopia: 1-in-3 Maculopathy Progression in 8 Years

A 2026 Am J Ophthalmol 8-year prospective cohort at Zhongshan Ophthalmic Center: 155 high-myopia children, 310 eyes. 31.3% had myopic-maculopathy progression in 8 years; adding the «2-year axial-length change rate» raised prediction accuracy from AUC 0.772 to 0.829, with a best cut-off of ~0.325 mm/year. This article explains how axial length becomes an early-warning tool for maculopathy, the mechanism, high-risk groups, and practical steps for Taiwanese parents.

Latest Research Uveitis Biologics

Refractory Noninfectious Uveitis — RUBI Biologics Trial

The 2026 multicentre RUBI trial compared adalimumab, tocilizumab, and anakinra. Adalimumab and tocilizumab showed no clear difference on the primary endpoint; anakinra was stopped early for insufficient efficacy. This article explains the limitations and why an adult trial cannot be directly extrapolated to Taiwan's paediatric NHI criteria.

Latest Research AMD Sleep apnea

Does Sleep Apnea Raise the Risk of AMD? — 2026 Meta-Analysis

A May 2026 systematic review in Am J Ophthalmol by Yaldo et al., pooling 8 studies (3.5M people, incl. Taiwan NHIRD). Key findings: OSA significantly associated with AMD — adjusted aOR 1.44 (moderate certainty, I²=0%); adjusted aHR 1.66; nAMD OR 1.76, non-neovascular 1.95. Mechanisms: intermittent hypoxia → oxidative stress + complement activation + choroidal hypoperfusion. OSA is one of few treatable systemic AMD risk factors, but evidence does not yet support routine screening.

Latest Research Pterygium Network meta-analysis

Pterygium Surgery: Recurrence vs Stability — 2026 NMA of 35 RCTs

A May 2026 network meta-analysis by Terres et al. in Am J Ophthalmol, pooling 35 RCTs (2,501 eyes) to compare 6 graft-fixation methods in pterygium surgery with conjunctival autograft. Key conclusions: fibrin glue had the lowest recurrence (OR 0.27); absorbable Vicryl 8-0 had the best graft stability; silk had the most complications and should be avoided. Choice balances recurrence vs stability, with cost, availability and surgeon experience all relevant.

Latest Research Diabetic retinopathy Dementia

Diabetic Retinopathy and Dementia Risk — 2026 TriNetX 770K Cohort

A May 2026 TriNetX 770K cohort study by Khangura et al. in Am J Ophthalmol. Key findings: more severe DR → stepwise higher all-cause and vascular dementia risk; PDR all-cause HR 1.58, VD HR 2.08; AD risk driven by diabetes itself with no clear gradient by DR severity. Retinal microvasculature is a visible proxy for systemic microvascular damage — fundus exams may serve as an early dementia risk marker.

Latest Research Keratitis HZO

Recurrent Stromal Keratitis After HZO — Why the 3 Months After Stopping Steroids Are Riskiest (2026 ZEDS Trial)

A May 2026 secondary analysis of the ZEDS SK end point by Jacobs et al. in Am J Ophthalmol. Key numbers: 105/527 (20%) with recurrent SK; 75% diagnosed at scheduled visits while asymptomatic; 38% of off-steroid relapses had stopped within prior 3 months; low-potency steroids sufficient for most (88% needed only frequency increase); only 10% needed oral valacyclovir; vision logMAR 0.10 → 0.13 (20/25 → 20/27). Cross-referenced with Taiwan NHI §10.7.1.1 (10-day course cap) and §14.2 (topical acyclovir restricted to V1 + keratitis/ulcer); ZEDS's 1-year suppression is not within NHI's listed conditions.

Latest Research Eye trauma Public health

Ophthalmic Trauma — The Overlooked Cause of Preventable Blindness: 2026 AJO Perspective + IGATES Registry

A May 2026 hybrid perspective in Am J Ophthalmol (Agrawal et al., APOTS taskforce) integrating IGATES registry data from 12 countries, 32 centers, 8,238 cases. Key numbers: closed-globe 56.9%, open-globe 34.0%; 70% presented > 12 h after injury; 30% had a final BCVA worse than 6/60 and 7% no light perception; 99% wore no eye protection; home 38.2% > work 19.4% > RTA 8.8% > fireworks 3.5%; AAO estimates up to 90% of eye injuries are preventable with appropriate eyewear. Plus high-risk groups, timing of care, and Taiwan-specific items flagged as needing local verification.

Patient Ed Cataract Astigmatism

Toric IOL for Cataract — Is It Worth It? Who, How Well, What Risks (2026 International Review)

A June 2026 narrative review in American Journal of Ophthalmology by the ESCRS Functional Vision Working Group (Verstraaten/Buzzi/Dickman et al.) integrates 13 systematic reviews, 10+ RCTs, and a 6,431-eye registry. This article digests, in clinic-friendly language: who is a candidate (regular corneal astigmatism ≥ 1.0 D), preoperative workup, toric IOL vs LRI / FSAK, rotation risk (90–97% within 5°, 0.65% need repositioning), special populations (post-LASIK, keratoconus, PEX, post-keratoplasty, Fuchs/DMEK), and Taiwan's fully self-pay reality.

Latest Research Dry Eye

Why Do My Dry-Eye Symptoms Not Match the Exam? — 2026 DREAM Study, 535 Patients

A February 2026 secondary analysis of the DREAM trial (Matar et al., Am J Ophthalmol; 535 moderate-to-severe DED patients) used 3 methods to evaluate symptom-sign discordance and found 77% of patients had mismatched subjective and objective severity. This digest covers the 4 phenotypes, who falls where, why it matters for treatment choice, and Taiwan NHI coverage rules for artificial tears and topical cyclosporine.

Latest Research Pediatric myopia

Monitoring Childhood Myopia: SER or Axial Length? A 2026 Meta-Analysis Perspective

Published March 2026 in Am J Ophthalmol, this systematic review and meta-analysis (Clark & Wong; 70 population-based studies) argues: SER should be the primary monitoring metric for most children; AL should be reserved for the minority entering the long-eye tail. Covers the 'AL 26 mm is not a universal threshold' point, the '90% vs 10%' framework, and which metric best predicts each of retinal pathology / cataract / glaucoma — with limitations and conflicts of interest disclosed.

Latest Research Pediatric myopia

Are DIMS Lenses Effective for Pediatric Myopia? Axial Length, Diopters, Evidence & Who Benefits

A new systematic review and meta-analysis (Al-Shammari et al., Am J Ophthalmol, Feb 2026) pooling 6 studies and 1224 children: DIMS lenses preserved ~0.37 D more diopters and ~0.16 mm less axial elongation than single-vision over 12 months. This article digests the new paper in clinic-friendly language: what DIMS is, mechanism, evidence, suitability, limitations, and how it sits among other myopia control options.

Patient Ed Cataract Surgery

Cataract Surgery Deep Selection — Modality, IOL, NHI vs Self-pay

Integrates 2021 AAO PPP, 2025 AAPPO, ESCRS 2024, FEMCAT trial and Taiwan NHI: 3-modality comparison (phaco vs FLACS vs MSICS), IOL classification (monofocal/toric/EDOF/multifocal/trifocal/LAL), monovision warning, astigmatism deep-dive (toric vs LRIs, residual), IOL formula detail (Barrett/Hill-RBF/Kane/Olsen/PEARL-DGS), post-LASIK calculation, NHI vs self-pay with sales-pitch warnings, scenario decision tree, Taiwan reality, 8 Q&As.

Patient Ed Glaucoma Surgery

Glaucoma Treatment Selection — Decision Logic, Side Effects & Taiwan Reality

Integrates 2025 AAO PPP, 2022 NICE, LiGHT 6-year, PTVT, EAGLE: SLT vs drops first-line, 5-PGA comparison, PAP warning, other drug-class side effects, Taiwan combination drops list, add-vs-switch logic, MIGS brand guide (iStent, Hydrus, XEN, PreserFlo, Kahook), traditional surgery ladder, angle-closure pathway, Taiwan NHI reality, 8 decision Q&As.

Red Flags Glaucoma

Glaucoma — The Silent Thief of Sight, Red Flags & Treatment Ladder

Integrates 2025 AAO PPPs, 2022 NICE NG81, European EGS guidelines and Taiwan epidemiology — open/closed/normal-tension types, acute red flags, SLT first-line, drugs and surgery ladder, home self-care and 8 myths debunked.

Patient Ed Cataract

Cataract Surgery — When, IOL Choice, Complications & Recovery

Integrates 2021 AAO PPP, 2025 AAPPO consensus and 31 ESCRS GRADE recommendations — when to operate (not by Snellen alone), phaco vs FLACS, monofocal/toric/EDOF/multifocal IOL trade-offs, and realistic complication rates.

Red Flags TED

Thyroid Eye Disease — Pathogenesis, Red Flags & Treatment Ladder

20-25% of Graves' patients develop clinically apparent TED; smoking raises risk 7-8x. Integrating 2021 EUGOGO, 2022 ATA/ETA and 2025 comparative review — CAS, severity grading, treatment ladder, smoking and thyroid control.

Red Flags Lacrimal tumor

6 Key Questions on Lacrimal Gland Tumor — Why pain? Can the eye be saved?

About 50% of lacrimal gland tumors are malignant. Reviewing the 2024 IJO meta-analysis and MD Anderson proton-therapy outcomes.

Red Flags Floaters

6 Floater Red Flags — when do floaters mean retinal emergency?

Most floaters are benign vitreous opacities — but sudden showers + flashes + field loss signal retinal detachment.

Myth-busting Myopia

8 pediatric myopia control myths — atropine, ortho-K, red light, outdoor time

Low-dose atropine, ortho-K, two hours outdoor — what works? Why was red light paused? Latest evidence in plain language.

Myth-busting Dry Eye

8 dry-eye myths — do artificial tears really make eyes drier?

Artificial tears don’t cause dry eye — but preserved drops harm corneal epithelium. Warm compress, MGD, omega-3 explained.

No matching articles. Try a different keyword or browse all topics.

Frequently Asked

The 15 most-searched ophthalmology questions

Click any question to expand. Each links to a full deep-dive article.

Do artificial tears make eyes drier? Will I become dependent?
No — what actually damages eyes is the BAK preservative inside (in nearly all multi-dose bottles). For more than 4 uses/day, switch to preservative-free single-dose vials. The "I need them more and more" feeling comes from underlying meibomian gland dysfunction (MGD) progressing — not the drops themselves. Full read: 8 Dry-Eye Myths.
If my eyes water all day, can it still be dry eye?
Opposite — reflex tearing is the textbook sign of evaporative DED (85% of dry eye). Insufficient lipid layer → fast evaporation → trigeminal reflex → accessory lacrimal flood of "watery tears". Patients tear AND feel dry/burning/blurry simultaneously. See 8 Dry-Eye Myths.
Does lutein cure dry eye or myopia?
No. Lutein + zeaxanthin protect the macula (evidence for age-related macular degeneration via AREDS2 trial) — minimal effect on dry eye or myopia. The supplement with theoretical basis for dry eye is Omega-3 (EPA/DHA), but the DREAM trial (NEJM 2018) was negative and AAO downgraded it to a conditional recommendation. See 8 Dry-Eye Myths.
Does pediatric myopia really need active control? At what age?
Yes, and the earlier the better. In Taiwan, 70% of 6th graders and over 80% of 12th graders are myopic; high myopia (≥−5.00 D) markedly raises future risk of retinal detachment, glaucoma, cataract, and myopic maculopathy. Evidence-based methods: low-dose atropine 0.05%, orthokeratology (Ortho-K), defocus spectacle lenses (DIMS). Typically start in 1st grade; consult earlier if family history. See Pediatric Myopia Control Guide.
Atropine 0.01% vs 0.05% — which is better?
The 2019 Hong Kong LAMP study (Yam JC et al) compared three concentrations head-to-head: 0.05% was most effective (~67% slowing), 0.025% moderate (~43%), 0.01% weaker (~27%). 0.05% has higher side effects (photophobia, near blur). Start with 0.05%; step down if intolerable. See Pediatric Myopia Control Guide.
Floaters — when should I see a doctor immediately?
Floaters (vitreous opacities) are usually benign posterior vitreous detachment (PVD). But see ophthalmology the same day if any of: (1) sudden new shower of floaters; (2) photopsia (lightning-like flashes); (3) visual field defect (curtain/shadow); (4) sudden vision loss. These are warnings of retinal break or detachment — delay can blind. Full read: 6 Floater Red Flags.
Red eye — allergic vs viral conjunctivitis?
Allergic: bilateral, intense itching, watery discharge, atopic history. Viral (adenovirus, "pink eye"): unilateral first then to the other eye in 1–2 days, marked redness, watery discharge, preauricular lymph node, highly contagious. Bacterial: unilateral, yellow purulent discharge, eyelids stuck on waking. Treatments differ — allergy needs antihistamines, virus needs cold compress + isolation, bacterial needs antibiotics.
Do I have to wait for cataract to "ripen" before surgery?
No — that's a 1980s large-incision era idea. Modern cataract surgery uses phacoemulsification + intraocular lens (IOL) implant, 2–3 mm micro-incision, ~20 minutes; earlier is actually easier (hyper-mature lenses are harder to break up). Consider surgery once vision affects daily life (<20/40 or severe night glare).
Refractive surgery (LASIK / SMILE) — who is a candidate?
Basic criteria: ≥20 years old, stable refraction for ≥1 year, sufficient corneal thickness, no severe dry eye or keratoconus, not pregnant or lactating. LASIK uses a corneal flap and is widely applicable; SMILE is flapless and minimally invasive — good for athletes, military/police, severe dry eye; PRK/TransPRK is surface-based and good for thin corneas. Thorough pre-op evaluation is essential.
Why do styes (hordeolum) keep recurring? Do they need surgery?
A stye is meibomian gland obstruction with inflammation. Recurrence usually stems from blepharitis, abnormal lipid secretion, makeup habits, or incomplete makeup removal. First-line: warm compresses (40°C × 10 min × 3–4 ×/day) + lid hygiene. Incision/drainage only if a pus-filled bump persists 1–2 weeks. Don't squeeze it yourself.
Do screens really damage eyes? Should I block blue light?
The real screen harm is reduced blink rate (15–20 → 5–7 /min) → dry eye and MGD; and near work driving myopia. "Blue light damages the retina" lacks strong evidence — AAO 2017 stance: typical screen blue-light dose is insufficient to harm the retina. Blue-blocking glasses ease eye strain but don't protect the retina. Most effective: 20-20-20 rule (every 20 min, look 20 feet away for 20 sec) + raise ambient lighting. See 8 Dry-Eye Myths.
Why monitor glaucoma if it's asymptomatic?
Glaucoma (mostly open-angle) is the "silent thief of sight" — the optic nerve is damaged first, peripheral visual field is lost before central acuity; patients often only notice when 30–50% of visual field is gone. Lost optic nerve fibers are irreversible. Annual IOP + visual field + OCT optic nerve exam is recommended for ages ≥40, family history, high myopia (>−6.00 D), or diabetes.
Retinal detachment — what are the warning signs?
Same-day ER for any of these four: (1) sudden surge of floaters (especially many ink-like spots); (2) photopsia (lightning-like flashes); (3) visual field defect (curtain pulling from periphery to center); (4) sudden vision blurring. High myopia (>−6.00 D), post-cataract surgery, or trauma raises risk. Golden treatment window: within 72 hours. Full read: 6 Floater Red Flags.
Do contact lenses "wear out" the eye?
Contacts reduce corneal oxygen, alter tear film, raise infection risk. Long-term overuse can cause corneal neovascularization, chronic conjunctivitis, severe dry eye, giant papillary conjunctivitis, and (rarely) corneal ulcer leading to blindness. Safe practice: dailies > monthlies, avoid >8 hr/day, never sleep in them, never reuse rinsing solution, regular eye-doctor checkups. See 8 Dry-Eye Myths.
Presbyopia — must I wear glasses? Are there surgical options?
Presbyopia is loss of crystalline lens accommodation; nearly universal after age 40. Options: (1) reading glasses (simplest), (2) bifocal/progressive lenses, (3) multifocal contacts, (4) PresbyLASIK, (5) cataract surgery with multifocal IOL (common in mid-late life). No absolute "must" — depends on whether it affects your reading.

Medical disclaimer · All content here is for general educational reference only. It is not individualized medical advice and cannot replace an in-person consultation, examination, or prescription. Any decision to start, stop, or change a medication should be made with your treating physician.
Support the author · Dr. Hsiao runs HsiaoEye as a personal patient-education project — no sponsorships, no affiliate links, no ad revenue. If anything here has helped you or your family, you're welcome to buy me a coffee so I can keep writing.